Photo by Mamta Popat / Arizona Daily Star

Health Care
Dependable Health Services
Physical Therapists Health Care
CENTRAL ARIZONA COLLEGE
DIRECTOR OF HEALTH INFORMATION MANAGEMENT Administrative & Professional
Jorgensen Brooks Group
Counselor Health Care
Sierra Tucson
Eating Disorders Program Coordinator Mechanical
Komatsu Equipment Co
Resident Field Mechanic Administrative & Professional
Tucson Urban League
CEO/President Sales and Marketing
Everready Glass
Sales Reps

Tucson-based ImaRx Therapeutics, Inc. narrowed its third-quarter loss by a third as it increased sales with its Abbokinase embolism-treatment drug, the company announced Thursday.

Net losses for the third quarter dropped by $1.3 million, to $2.7 million compared with the same period in 2006.

Revenue for the quarter, which ended Sept. 30, was $2.3 million, compared to $0.2 million during the third quarter for 2006.

The company is currently conducting clinical trials for its SonoLysis stroke therapy and expects results by mid-2008.